Sign up to get full access to all our latest press releases and newsletters.
Sign UpSeptember 3rd, 2024
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
August 13th, 2024
Organigram Reports Third Quarter Fiscal 2024 Results
August 7th, 2024
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
July 24th, 2024
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
May 15th, 2024
Organigram Reports Second Quarter Fiscal 2024 Results
April 8th, 2024
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
March 26th, 2024
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
February 28th, 2024
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty
February 13th, 2024